PEGylated carboxyhemoglobin bovine (SANGUINATE) ameliorates myocardial infarction in a rat model. by Prolong Pharma | Dec 1, 2018 | Publications
Early Experiences With PEGylated Carboxyhemoglobin Bovine in Anemic Jehovah’s Witnesses: A Case Series and Review of the Literature. by Prolong Pharma | Dec 1, 2018 | Publications
PEGylated carboxyhemoglobin bovine (SANGUINATE) ameliorates myocardial infarction in a rat model. by Prolong Pharma | Dec 1, 2018 | Publications
Investigational use of PEGylated carboxyhemoglobin bovine in a Jehovah’s Witness with hemorrhagic shock by Prolong Pharma | Oct 1, 2018 | Publications
Pharmacologically increasing collateral perfusion during acute stroke using a carboxyhemoglobin gas transfer agent (Sanguinate™) in spontaneously hypertensive rats. by Prolong Pharma | May 1, 2018 | Publications
A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease by Prolong Pharma | Jan 1, 2018 | Publications